J (and) J’s two-dose Ebola vax regimen safe: Study
London, Sep 15 : The two-dose vaccine against Ebola virus developed by US drug maker Johnson and Johnson is safe, well tolerated and produces a strong immune response in people over the age of one, according to two new papers published in The Lancet …